Search

In response to intense pressure, technology companies have enacted policies to combat misinformation1–4. The enforcement of these policies has, however, led to technology companies being regularly accused of political bias5–7. We argue that differential sharing of misinformation by people identifying with different political groups8–15 could lead to political asymmetries in enforcement, even by unbiased policies. We first analysed 9,000 politically active Twitter users during the US 2020 presidential election. Although users estimated to be pro-Trump/conservative were indeed substantially more likely to be suspended than those estimated to be pro-Biden/liberal, users who were pro-Trump/conservative also shared far more links to various sets of low-quality news sites—even when news quality was determined by politically balanced groups of laypeople, or groups of only Republican laypeople—and had higher estimated likelihoods of being bots. We find similar associations between stated or inferred conservatism and low-quality news sharing (on the basis of both expert and politically balanced layperson ratings) in 7 other datasets of sharing from Twitter, Facebook and survey experiments, spanning 2016 to 2023 and including data from 16 different countries. Thus, even under politically neutral anti-misinformation policies, political asymmetries in enforcement should be expected. Political imbalance in enforcement need not imply bias on the part of social media companies implementing anti-misinformation policies.We find that conservatives tend to share more low-quality news through social media than liberals, and so even if technology companies enact politically neutral anti-misinformation policies, political asymmetries in enforcement should be expected. [ABSTRACT FROM AUTHOR]

The question of whether tumorigenic cancer stem cells exist in human melanomas has arisen in the last few years. Here we show that in melanomas, tumour stem cells (MTSCs, for melanoma tumour stem cells) can be isolated prospectively as a highly enriched CD271+ MTSC population using a process that maximizes viable cell transplantation. The tumours sampled in this study were taken from a broad spectrum of sites and stages. High-viability cells isolated by fluorescence-activated cell sorting and re-suspended in a matrigel vehicle were implanted into T-, B- and natural-killer-deficient Rag2−/−γc−/− mice. The CD271+ subset of cells was the tumour-initiating population in 90% (nine out of ten) of melanomas tested. Transplantation of isolated CD271+ melanoma cells into engrafted human skin or bone in Rag2−/−γc−/− mice resulted in melanoma; however, melanoma did not develop after transplantation of isolated CD271− cells. We also show that in mice, tumours derived from transplanted human CD271+ melanoma cells were capable of metastatsis in vivo. CD271+ melanoma cells lacked expression of TYR, MART1 and MAGE in 86%, 69% and 68% of melanoma patients, respectively, which helps to explain why T-cell therapies directed at these antigens usually result in only temporary tumour shrinkage. [ABSTRACT FROM AUTHOR]